Hogan Lovells Guides Glucose Tester In $54M Fundraising

Law360, New York (November 1, 2011, 4:39 PM EDT) -- Sensors for Medicine and Science Inc.’s latest funding push attracted $54 million from Delphi Ventures and other venture capital firms keen to bring its implantable glucose monitoring system to market, the medical device company announced Tuesday.

Delphi, a newcomer to SMSI, led the way in the Series D equity financing, while existing investors New Enterprise Associates, HealthCare Ventures, Anthem Capital and Greenspring Associates also contributed capital for the development effort.

The fourth round of financing arrives shortly after SMSI reported the success of a human pilot...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.